Home > Insider Trading > Filing (0001127602-24-028232)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882095	Gilead Sciences Inc.	GILD	Biological Products, (No Disgnostic Substances) (2836)	943047598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1792150	Merdad Parsey	Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-11-27	57,294	$57.92	156,893	No	4	M	Direct
Common Stock	Acquisiton	2024-11-27	88,119	$65.38	245,012	No	4	M	Direct
Common Stock	Disposition	2024-11-27	57,294	$91.79	187,718	No	4	S	Direct
Common Stock	Disposition	2024-11-27	88,119	$92.00	99,599	No	4	S	Direct
Common Stock	Disposition	2024-11-27	5,200	$91.80	94,399	No	4	S	Direct
Common Stock	Disposition	2024-11-27	3,199	$91.80	91,200	No	4	S	Direct
Common Stock	Disposition	2024-11-27	10,399	$92.00	80,801	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2024-11-27	57,294	$0.00	57,294	$57.92
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2024-11-27	88,119	$0.00	88,119	$65.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
64,376		2032-03-10	No	4	M	Direct
196		2029-11-10	No	4	M	Direct

Footnotes

Sale prices reported for the transactions reported here range from $91.451 to $92.095. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $91.458 to $92.04. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Sale prices reported for the transactions reported here range from $91.451 to $92.035. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.